Skip to main content

hydromorphone

Generic: HYDROMORPHONE HYDROCHLORIDE·Brand: DILAUDID, DILAUDID-HP, Dilaudid, Dilaudid Cough, EXALGO, HYDROMORPHONE HYDROCHLORIDE, PALLADONE

hydromorphone: developed by 1 company · 1 clinical trial tracked · 1 FDA decision.

hydromorphone evidence translation

What we can confirm

1 FDA record · 1 tracked trial

What it means

Source-backed records connect hydromorphone to LCI; that link alone does not prove the drug works.

What to watch

Watch active trials and any change in FDA or trial status.
BioSniper AIPage evidence connected

Prepared research question

How could hydromorphone → LCI affect its developer, and what evidence supports the link?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence0 indications · 1 study sponsors

Related indications

No linked indication is available.

Development Pipeline (1)
CompanyPhase
LANNETT CO INC (LCI)Approved
Clinical Trials (1)

Buprenorphine for Analgesia in Older Adults With Acute Fractures in the Emergency Department: a Randomized Controlled Study

NCT07430345·Phase 1·COLL
Not yet recruiting

Primary endpoint: Difference in pain scores

InterventionalRandomizedsingle48 targetStarted 2026-04Completion 2027-011 site · United StatesThe Cooper Health System
FDA Decisions1 records
Approval1 INDICATIONS AND USAGE Hydromorphone hydrochloride oral solution and hydromorphone hydrochloride tablets are indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. Hydromorphone hydrochloride oral solution and hydromorphone hydrochloride tablets contain hydromorphone, an opioid agonist, and are indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are (LCI)FDA ↗
ANDA078439OralTablet

Frequently asked questions

Who is developing hydromorphone?

hydromorphone is being developed by LANNETT CO INC.

How many clinical trials involve hydromorphone?

BioSniper tracks 1 clinical trial involving hydromorphone.

What is hydromorphone's latest FDA decision?

The most recent tracked FDA decision for hydromorphone is Approval for 1 INDICATIONS AND USAGE Hydromorphone hydrochloride oral solution and hydromorphone hydrochloride tablets are indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. Hydromorphone hydrochloride oral solution and hydromorphone hydrochloride tablets contain hydromorphone, an opioid agonist, and are indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are , dated December 9, 2009.